# A Study in Healthy Men to Compare 2 Different Formulations of Alteplase

> **NCT04419493** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Alteplase (from modified manufacturing process)
- **DRUG:** Alteplase (from current manufacturing process)
- **DRUG:** Heparin-Natrium-5000-ratiopharm (unfractionated heparin)

## Key facts

- **NCT ID:** NCT04419493
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-23
- **Primary completion:** 2021-06-21
- **Final completion:** 2021-06-21
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04419493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04419493, "A Study in Healthy Men to Compare 2 Different Formulations of Alteplase". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04419493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*